Diabetes type | Type 1 | Type 2 | ||
---|---|---|---|---|
(value) | (n) | (value) | (n) | |
Threshold measure | ||||
Below target value | ||||
LDL index value | ||||
Total, patients (%) | 342 (60.2) | 568 | 696 (63.0) | 1105 |
With CV history (LDL < 70 mg/dl), patients (%) | 15 (31.9) | 47 | 130 (39.5) | 329 |
Without CV history (LDL < 100 mg/dl), patients (%) | 327 (62.8) | 521 | 566 (72.9) | 776 |
non-HDL index value | ||||
Total, patients (%) | 870 (70.5) | 1234 | 1349 (61.7) | 2187 |
With CV history (non-HDL < 100 mg/dl), patients (%) | 46 (51.1) | 90 | 285 (41.9) | 680 |
Without CV history (non-HDL < 130 mg/dl), patients (%) | 824 (72.0) | 1144 | 1064 (70.6) | 1507 |
Clinical action measure | ||||
Treatment and contraindication status | ||||
LDL index value | ||||
LDL ≥ 70 mg/dl, patients | ||||
Treatment initiation or intens. [init.] | 3 [3] | 27 [23] | ||
Contraindication | 2 | 4 | ||
LDL ≥ 100 mg/dl, patients | ||||
Treatment initiation or intens. [init.] | 23 [22] | 26 [23] | ||
Contraindication | 2 | 5 | ||
non-HDL index value | ||||
non-HDL ≥ 100 mg/dl, patients | ||||
Treatment initiation or intens. [init.] | 3 [3] | 51 [36] | ||
Contraindication | 2 | 18 | ||
non-HDL ≥ 130 mg/dl, patients | ||||
Treatment initiation or intens. [init.] | 42 [40] | 53 [46] | ||
Contraindication | 2 | 3 | ||
Total | ||||
LDL index value | ||||
Total, patients (%) | 372 (65.5) ° | 758 (68.6) ° | ||
With CV history, patients (%) | 20 (42.5) $ | 161 (48.9) ° | ||
Without CV history, patients (%) | 352 (67.6) ° | 597 (76.9) ° | ||
non-HDL index value | ||||
Total, patients (%) | 919 (74.5) ° | 1474 (67.4) ° | ||
With CV history, patients (%) | 51 (56.7) ° | 354 (52.1) ° | ||
Without CV history, patients (%) | 868 (75.9) ° | 1120 (74.3) ° |